Skip to content
HowShorted

Corvus Pharmaceuticals, Inc. short interest in 2020

In 2020, Corvus Pharmaceuticals, Inc.'s disclosed short interest ran from 4.59% of shares outstanding on 15 Jan 2020 to 4.27% on 31 Dec 2020, a change of -0.32 percentage points. The year's high was 5.77% on 31 Jul 2020 and its low 4.06% on 15 May 2020, averaging 4.78% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.65 days on 30 Apr 2020. Full history: Corvus Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Corvus Pharmaceuticals, Inc. in 2020

2020 in figures

Start of year
4.59% (15 Jan 2020)
End of year
4.27% (31 Dec 2020)
Change
-0.32 pp
High
5.77% (31 Jul 2020)
Low
4.06% (15 May 2020)
Average
4.78%
Highest days to cover
19.65 (30 Apr 2020)
SEC filings marked
8

Every report in 2020

Corvus Pharmaceuticals, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 20204.59%10.48
31 Jan 20204.33%8.21
14 Feb 20204.53%6.12
28 Feb 20204.34%8.13
13 Mar 20204.26%5.85results (8-K), 10-K filed
31 Mar 20204.31%11.97
15 Apr 20204.31%13.94
30 Apr 20204.24%19.6510-Q filed, results (8-K)
15 May 20204.06%5.33
15 Jul 20204.41%1.00
31 Jul 20205.77%2.5910-Q filed, results (8-K)
14 Aug 20205.65%5.85
31 Aug 20205.77%10.15
15 Sep 20205.71%5.39
30 Sep 20204.89%8.25
15 Oct 20205.32%1.00
30 Oct 20205.44%10.2110-Q filed, results (8-K)
13 Nov 20204.94%10.12
30 Nov 20204.92%11.26
15 Dec 20204.40%6.46
31 Dec 20204.27%7.47

See also: Corvus Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.